ORGANOVO HOLDINGS
Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
ORGANOVO HOLDINGS
Industry:
Biotechnology Medical Therapeutics
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.organovo.com
Total Employee:
51+
Status:
Active
Contact:
(858)550-9994
Total Funding:
112.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Board_member
Current Employees Featured
Craig Kussman Chief Financial Officer @ Organovo Holdings
Chief Financial Officer
2016-08-01
Barry Michaels CFO @ Organovo Holdings
CFO
Gabor Forgacs Scientific Founder @ Organovo Holdings
Scientific Founder
2007-10-01
Sharon Collins Presnell CTO&Executive Vice President @ Organovo Holdings
CTO&Executive Vice President
Curtis Tyree SVP, Strategy and Business Development @ Organovo Holdings
SVP, Strategy and Business Development
2022-02-01
Doug Cohen Member of the Board @ Organovo Holdings
Member of the Board
2020-09-01
Keith Murphy Chairman and CEO @ Organovo Holdings
Chairman and CEO
Founder
Stock Details
Investors List
Eric Del Balso
Eric Del Balso investment in Post-IPO Equity - Organovo Holdings
SternAegis
SternAegis investment in Post-IPO Equity - Organovo Holdings
Spencer Trask & Co
Spencer Trask & Co investment in Post-IPO Equity - Organovo Holdings
Michael Brams
Michael Brams investment in Series A - Organovo Holdings
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-18 | Organovo Welcomes New Sr. Vice President of Strategy and Business Development |
Official Site Inspections
http://www.organovo.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.92 K
- Host name: 52.18.197.104.bc.googleusercontent.com
- IP address: 104.197.18.52
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Organovo Holdings"
Who We Are - Organovo, Inc.
Organovo creates human models of inflammatory bowel disease (IBD) using our 3D tissue technologies and uses them to understand, invent, and develop the best drug therapies for …See details»
Organovo - Wikipedia
Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D …See details»
Organovo Holdings - Crunchbase Company Profile
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.See details»
Leadership Team - Organovo, Inc.
With decades of leadership experience in the life science industry, our team fosters an ethos of innovation to develop regenerative medicine therapies aimed at treating a range of serious …See details»
Organovo - Pioneering 3D Human Tissues
Organovo is at the forefront of 3D bioprinting technology, revolutionizing drug discovery and development with innovative human tissue models. Visit Organovo WebsiteSee details»
Organovo - businessabc.net
Feb 27, 2025 Organovo was founded in 2007 by three experienced researchers, Gabor Forgacs, Mike Renard and Keith Murphy, who combined their knowledge in the fields of engineering, …See details»
Organovo Holdings, Inc. - LinkedIn
Organovo Holdings, Inc. Biotechnology Research San Diego, California 11,326 followers Discovering drugs using highly customized human tissues as living, dynamic models of human …See details»
Investor Presentation (December 2023) - Organovo Holdings, Inc.
Forward-Looking Statements Certain statements contained in this presentation or in other documents of Organovo Holdings, Inc. (the “Company” or “Organovo”) and of any of its …See details»
Organovo, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Organovo, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
ORGANOVO HOLDINGS, INC.
Organovo Holdings, Inc. (“Organovo Holdings,” “we,” “us,” “our,” the “Company” and “our Company”) is an early-stage biotechnology company that focuses on building high fidelity, 3D …See details»
Organovo Provides Business Update | Organovo Holdings, Inc.
2 days ago SAN DIEGO , March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company …See details»
About - Organovo, Inc.
© 2025 Organovo Holdings Inc. 11555 Sorrento Valley Road, Suite 100 San Diego, CA 92121See details»
Organovo Holdings (ONVO) Company Profile & Description
Mar 21, 2025 Company profile for Organovo Holdings, Inc. (ONVO) stock, with a description, list of executives, contact details and other key facts.See details»
Organovo Holdings, Inc. (ONVO): history, ownership, mission, how …
Discover Organovo Holdings, Inc.s mission, ownership, and history. Learn how it generates revenue and operates in the regenerative medicine field.See details»
Organovo Holdings - Funding, Financials, Valuation & Investors
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.See details»
Board of Directors - Organovo, Inc.
Mr. Murphy serves as co-chair of the Board of No Patient Left Behind, and on the Board of Directors of the California Life Sciences Association, the state’s life science industry public …See details»
Organovo Holdings, Inc.: Resilience Amidst Market Challenges ? A …
2 days ago Introduction On March 27, 2025, Organovo Holdings, Inc. (Nasdaq: ONVO), a pioneering clinical-stage biotechnology company known for its innovative approaches to …See details»
Contact - Organovo, Inc.
Contact Form Thank you for your interest in Organovo. Corporate Headquarters Contact Form Thank you for your interest in Organovo. Please fill out and submit the form below for …See details»
Organovo Issues Business Update - Quick Facts | Nasdaq
2 days ago Organovo now expects to establish an operating cadence that leverages existing capital at a rate sufficient to push through the end of fiscal 2026.See details»
Pipeline - Organovo, Inc.
Organovo is also advancing FXR314 for the treatment of other Inflammatory Bowel Diseases including Crohn’s Disease as well as diseases of the Liver including NASH and Primary Biliary …See details»